| 000 | 01562 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513213231.0 | ||
| 264 | 0 | _c20001128 | |
| 008 | 200011s 0 0 eng d | ||
| 022 | _a0268-1315 | ||
| 024 | 7 |
_a10.1097/00004850-200015030-00001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEmsley, R A | |
| 245 | 0 | 0 |
_aA comparison of the effects of quetiapine ('seroquel') and haloperidol in schizophrenic patients with a history of and a demonstrated, partial response to conventional antipsychotic treatment. PRIZE Study Group. _h[electronic resource] |
| 260 |
_bInternational clinical psychopharmacology _cMay 2000 |
||
| 300 |
_a121-31 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xpharmacology |
| 650 | 0 | 4 |
_aDibenzothiazepines _xpharmacology |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHaloperidol _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aQuetiapine Fumarate |
| 650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aRaniwalla, J | |
| 700 | 1 | _aBailey, P J | |
| 700 | 1 | _aJones, A M | |
| 773 | 0 |
_tInternational clinical psychopharmacology _gvol. 15 _gno. 3 _gp. 121-31 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00004850-200015030-00001 _zAvailable from publisher's website |
| 999 |
_c10821653 _d10821653 |
||